Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum.
Cheng WM, Chan KH, Chen HL, Luo RX, Ng SP, Luk W, Zheng BJ, Ji MF, Liang JS, Sham JS, Wang DK, Zong YS, Ng MH.
Cheng WM, et al. Among authors: sham js.
Int J Cancer. 2002 Feb 1;97(4):489-92. doi: 10.1002/ijc.1641.
Int J Cancer. 2002.
PMID: 11802211